Crossmark

Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment

Crossref DOI link: https://doi.org/10.1007/s00044-024-03267-3

Published Online: 2024-06-26

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Jingyi

Staler, Dalton W.

Mahato, Ram I. https://orcid.org/0000-0003-3588-0434
License Information

Text and Data Mining valid from 2024-06-26

Version of Record valid from 2024-06-26
More Information

Article History

Received: 30 March 2024

Accepted: 19 June 2024

First Online: 26 June 2024

Compliance with ethical standards

:

: The authors declare no competing interests.